Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05110014 · ClinicalTrials.gov registry record · NA
Substudy of Protocol NCT03843957 - Effect of mPATH on Screening for Depression, Fall Risk, and Safety
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 23,026
- Enrollment target
NCT05110014 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 23,026 participants.
The verdict
NCT05110014, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 23,026 participants
- Enrollment target
Study Summary
This is a sub-study for data analysis of data collected as part of the larger randomized controlled trial "Effectiveness and Implementation of mPATH-CRC" (NCT03843957) to determine if self-administered screening with an iPad increases the detection of patients with depression, falls, and intimate partner violence.
Interventions
- OTHER Primary Care Office Visits
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23,026 participants |
| Start Date | 2019-06-24 |
| Est. Completion | 2020-02-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05110014
The ClinicalTrials.gov registry entry for NCT05110014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23,026 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Primary Care Office Visits is the first listed.
NCT05110014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05110014 about?
NCT05110014 is a clinical study titled "Substudy of Protocol NCT03843957 - Effect of mPATH on Screening for Depression, Fall Risk, and Safety". This is a sub-study for data analysis of data collected as part of the larger randomized controlled trial "Effectiveness and Implementation of mPATH-CRC" (NCT03843957) to determine if self-administered screening with an iPad increases the detection of patients with depression, falls, and intimate pa...
What is the current status of trial NCT05110014?
This trial is currently completed. It is a NA study. The enrollment target is 23,026 participants. The study started on 2019-06-24. Estimated completion is 2020-02-27.
What interventions are being tested in trial NCT05110014?
The interventions under investigation include: Primary Care Office Visits (OTHER).
Who is sponsoring clinical trial NCT05110014?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.